Stocks and Finance

Biogen Idec

Biogen Idec 4/26/2012

14:43 : Forbes Earnings Preview: Biogen Idec - Leading up to Biogen Idec's (BIIB) announcement of its first quarter earnings on Tuesday, May 1, 2012 analysts have become more wary as expectations have fallen over the past month to earnings of $1.44 per share from earnings of $1.47 per share.
Source : forbes-com

Biogen Idec 2/28/2012

16:44 : Biogen Idec gets approval for new Avonex delivery method - Biotech company Biogen Idec, which employs 900 in Research Triangle Park, on Tuesday announced approval from the Food and Drug Administration to use a new way to deliver its multiple sclerosis drug Avonex. The active ingredient for ...
Source : bizjournals-com

Biogen Idec 2/8/2012

03:02 : Biogen Idec adds car chargers - Local drugmaker Biogen Idec dedicated 10 electric car rechargers Tuesday at its facility in Research Triangle Park as part of the federal government's push for electric cars.Click to Continue »
Source : newsobserver-com

Biogen Idec 2/7/2012

10:47 : Biogen Idec opens 10 electric car recharging stations - Local drug maker Biogen Idec is dedicating 10 electric car rechargers this morning at its facility in Research Triangle Park. The number of rechargers represents a new standard for corporate…Click to Continue »
Source : newsobserver-com

Biogen Idec 1/31/2012

08:17 : Biogen Idec revenue up 9% in fourth quarter - LONDON (MarketWatch) -- Biogen Idec Inc. Tuesday reported fourth-quarter earnings of $300.2 million, or $1.24 a share, compared with $240.3 million, or $1.00 a share, in the year-ago period. Revenue increased 9% to $1.3 billion from ...
Source : marketwatch-com

Biogen Idec 12/6/2011

11:37 : Samsung-Quintiles venture teams up with Biogen Idec - Samsung Biologics, a company that Durham-based Quintiles has a minority stake in, is teaming up with Biogen Idec on a $300 million venture to develop and sell biotechnology-based medicines.
Source : newsobserver-com

Biogen Idec 10/25/2011

15:12 : Forbes Earnings Preview: Biogen Idec - Optimism surrounds Biogen Idec (BIIB), as it gets ready to report its third quarter results on Friday, October 28, 2011. Analysts are expecting Biogen Idec to book a profit of $1.51 a share, up from $1.33 a year ago.
Source : forbes-com

Biogen Idec 6/20/2011

16:03 : Biogen-IDEC ([[BIIB]] +4.1%) closes at the top of the S&P leader board ... - Biogen-IDEC (BIIB +4.1%) closes at the top of the S&P leader board after ISI Group ups it to Buy, citing a strong pipeline, and noting its new BG-12 multiple-sclerosis pill can double earnings over the next three to four years. ...
Source : seekingalpha-com
actualidad Biogen Idec -
Logo Biogen Idec


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts